NutriSystem (NTRI) Upgraded by ValuEngine to Sell

Share on StockTwits

ValuEngine upgraded shares of NutriSystem (NASDAQ:NTRI) from a strong sell rating to a sell rating in a research report released on Friday.

Several other research analysts have also recently weighed in on the stock. Barrington Research restated a hold rating on shares of NutriSystem in a research report on Friday, October 5th. BidaskClub cut shares of NutriSystem from a hold rating to a sell rating in a research report on Saturday, August 18th. Zacks Investment Research upgraded shares of NutriSystem from a hold rating to a buy rating and set a $45.00 price objective for the company in a research report on Thursday, August 2nd. B. Riley boosted their price objective on shares of NutriSystem from $52.00 to $53.00 and gave the stock a buy rating in a research report on Tuesday, July 31st. Finally, DA Davidson cut shares of NutriSystem from a buy rating to a neutral rating and dropped their price objective for the stock from $45.00 to $40.00 in a research report on Tuesday, July 31st. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus target price of $46.50.

NTRI stock traded up $1.09 during trading on Friday, hitting $37.10. The company had a trading volume of 771,983 shares, compared to its average volume of 820,897. NutriSystem has a 12 month low of $26.06 and a 12 month high of $60.80. The stock has a market capitalization of $1.09 billion, a PE ratio of 18.93, a price-to-earnings-growth ratio of 1.78 and a beta of 1.27.

NutriSystem (NASDAQ:NTRI) last posted its quarterly earnings data on Monday, July 30th. The company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.06. NutriSystem had a net margin of 7.94% and a return on equity of 43.29%. The firm had revenue of $191.30 million during the quarter, compared to analysts’ expectations of $189.07 million. During the same quarter in the previous year, the company posted $0.80 EPS. NutriSystem’s revenue was down 1.8% on a year-over-year basis. On average, equities research analysts anticipate that NutriSystem will post 2.09 earnings per share for the current year.

Institutional investors have recently modified their holdings of the business. Atria Investments LLC bought a new stake in shares of NutriSystem during the 2nd quarter valued at $394,000. First Mercantile Trust Co. bought a new stake in shares of NutriSystem during the 2nd quarter valued at $119,000. Aperio Group LLC bought a new stake in shares of NutriSystem during the 2nd quarter valued at $313,000. Guggenheim Capital LLC raised its position in shares of NutriSystem by 8.3% during the 1st quarter. Guggenheim Capital LLC now owns 56,018 shares of the company’s stock valued at $1,509,000 after acquiring an additional 4,308 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of NutriSystem during the 2nd quarter valued at $259,000.

NutriSystem Company Profile

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.

Featured Article: How much money do you need to begin day trading?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

NutriSystem  Upgraded by ValuEngine to Sell
NutriSystem Upgraded by ValuEngine to Sell
Wyndham Destinations  Downgraded to Hold at Zacks Investment Research
Wyndham Destinations Downgraded to Hold at Zacks Investment Research
Office Depot Inc  Expected to Post Earnings of $0.12 Per Share
Office Depot Inc Expected to Post Earnings of $0.12 Per Share
Kennametal  Downgraded by ValuEngine to “Sell”
Kennametal Downgraded by ValuEngine to “Sell”
Steelcase  Downgraded by ValuEngine to Hold
Steelcase Downgraded by ValuEngine to Hold
Innospec  Lowered to Hold at ValuEngine
Innospec Lowered to Hold at ValuEngine


Leave a Reply

© 2006-2018 Ticker Report. Google+.